334 related articles for article (PubMed ID: 25991422)
1. Complications and Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement With Edwards SAPIEN & SAPIEN XT Valves: A Meta-Analysis of World-Wide Studies and Registries Comparing the Transapical and Transfemoral Accesses.
Ghatak A; Bavishi C; Cardoso RN; Macon C; Singh V; Badheka AO; Padala S; Cohen MG; Mitrani R; O'Neill W; De Marchena E
J Interv Cardiol; 2015 Jun; 28(3):266-78. PubMed ID: 25991422
[TBL] [Abstract][Full Text] [Related]
2. European real world trans-catheter aortic valve implantation: systematic review and meta-analysis of European national registries.
Krasopoulos G; Falconieri F; Benedetto U; Newton J; Sayeed R; Kharbanda R; Banning A
J Cardiothorac Surg; 2016 Nov; 11(1):159. PubMed ID: 27899128
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Renal Failure Requiring Hemodialysis Following Transcatheter Aortic Valve Replacement.
Ladia V; Panchal HB; O׳Neil TJ; Sitwala P; Bhatheja S; Patel R; Ramu V; Mukherjee D; Mahmud E; Paul TK
Am J Med Sci; 2016 Sep; 352(3):306-13. PubMed ID: 27650237
[TBL] [Abstract][Full Text] [Related]
4. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
5. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R;
JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609
[TBL] [Abstract][Full Text] [Related]
6. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
[TBL] [Abstract][Full Text] [Related]
7. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
[TBL] [Abstract][Full Text] [Related]
8. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
[TBL] [Abstract][Full Text] [Related]
9. Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement.
Guo R; Xie M; Yim WY; Wu W; Jiang W; Wang Y; Hu X
BMC Cardiovasc Disord; 2021 Jul; 21(1):358. PubMed ID: 34320946
[TBL] [Abstract][Full Text] [Related]
10. Comparison of balloon-expandable valves versus self-expandable valves in high-risk patients undergoing transcatheter aortic valve replacement for severe aortic stenosis.
Chang HH; Chen IM; Chen PL; Hsu TL; Lin SM; Chen YH
J Chin Med Assoc; 2015 Jun; 78(6):331-8. PubMed ID: 25823678
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events in patients undergoing transfemoral versus transapical transcatheter aortic valve implantation using edwards valve for severe aortic stenosis.
Panchal HB; Ladia V; Amin P; Patel P; Veeranki SP; Albalbissi K; Paul T
Am J Cardiol; 2014 Dec; 114(12):1882-90. PubMed ID: 25438917
[TBL] [Abstract][Full Text] [Related]
12. Transapical transcatheter aortic valve replacement in patients with or without prior coronary artery bypass graft operation.
Voudris KV; Wong SC; Kaple R; Kampaktsis PN; de Biasi AR; Weiss JS; Devereux R; Krieger K; Kim L; Swaminathan RV; Feldman DN; Singh H; Skubas NJ; Minutello RM; Bergman G; Salemi A
J Cardiothorac Surg; 2016 Nov; 11(1):158. PubMed ID: 27899140
[TBL] [Abstract][Full Text] [Related]
13. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter aortic valve replacement using the SAPIEN 3 valve versus surgical aortic valve replacement using the rapid deployment INTUITY valve: Midterm outcomes.
Useini D; Beluli B; Christ H; Schlömicher M; Ewais E; Haldenwang P; Patsalis P; Moustafine V; Bechtel M; Strauch J
J Card Surg; 2021 Feb; 36(2):610-617. PubMed ID: 33386755
[TBL] [Abstract][Full Text] [Related]
15. Transaortic transcatheter aortic valve implantation using SAPIEN XT or SAPIEN 3 valves in the ROUTE registry.
Romano M; Frank D; Cocchieri R; Jagielak D; Bonaros N; Aiello M; Lapeze J; Laine M; Chocron S; Muir D; Eichinger W; Thielmann M; Labrousse L; Arne Rein K; Verhoye JP; Gerosa G; Baumbach H; Deutsch C; Bramlage P; Thoenes M; Bapat V
Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):757-764. PubMed ID: 28582580
[TBL] [Abstract][Full Text] [Related]
16. Transapical versus transfemoral approach and risk of acute kidney injury following transcatheter aortic valve replacement: a propensity-adjusted analysis.
Thongprayoon C; Cheungpasitporn W; Srivali N; Harrison AM; Kittanamongkolchai W; Greason KL; Kashani KB
Ren Fail; 2017 Nov; 39(1):13-18. PubMed ID: 27767371
[TBL] [Abstract][Full Text] [Related]
17. Transaortic transcatheter aortic valve implantation: experience from the Kiel study.
Petzina R; Lutter G; Wolf C; Kühl C; Freitag-Wolf S; Panholzer B; Bramlage P; Frey N; Cremer J; Frank D
Interact Cardiovasc Thorac Surg; 2017 Jan; 24(1):55-62. PubMed ID: 27600910
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies.
Généreux P; Head SJ; Van Mieghem NM; Kodali S; Kirtane AJ; Xu K; Smith C; Serruys PW; Kappetein AP; Leon MB
J Am Coll Cardiol; 2012 Jun; 59(25):2317-26. PubMed ID: 22503058
[TBL] [Abstract][Full Text] [Related]
19. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy.
Blackstone EH; Suri RM; Rajeswaran J; Babaliaros V; Douglas PS; Fearon WF; Miller DC; Hahn RT; Kapadia S; Kirtane AJ; Kodali SK; Mack M; Szeto WY; Thourani VH; Tuzcu EM; Williams MR; Akin JJ; Leon MB; Svensson LG
Circulation; 2015 Jun; 131(22):1989-2000. PubMed ID: 25832034
[TBL] [Abstract][Full Text] [Related]
20. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
